Rasagiline Tablet
Product Images NDC 0093-3060

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 0093-3060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of rasagiline with a methylsulfonic acid (mesylate) moiety. The structure includes an indane ring system attached to an amine group bonded to a propargyl group.*

FDA Label Image

Image 2

Label for Rasagiline Tablets 0.5 mg by Teva Pharmaceuticals USA, Inc. Shows prescription-only status and package size of 30 tablets. Includes serialization coding area, NDC 0093-3060-56, storage instructions, and distributor information. The label highlights the active ingredient Rasagiline with a strength of 0.5 mg per tablet in oral tablet form.*

FDA Label Image

Image 3

Rasagiline 1 mg tablets label from Teva Pharmaceuticals USA, Inc. The label includes dosage information specifying each tablet contains 1 mg rasagiline. It indicates an oral prescription drug with a package containing 30 tablets. The label also displays storage instructions and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.